glutathione disulfide has been researched along with methyl methanesulfonate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chung, H; Fried, J; Jarabak, J | 1 |
| Dolezel, P; Frydrych, I; Mlejnek, P | 1 |
2 other study(ies) available for glutathione disulfide and methyl methanesulfonate
| Article | Year |
|---|---|
Irreversible inhibition of the human placental NADP-linked 15-hydroxyprostaglandin dehydrogenase/9-ketoprostaglandin reductase by glutathione thiosulfonate.
Topics: Binding Sites; Enzyme Inhibitors; Glutathione; Glutathione Disulfide; Humans; Hydroxyprostaglandin Dehydrogenases; Methyl Methanesulfonate; NADP; Oxidation-Reduction; Placenta; Prostaglandins A; Time Factors | 1987 |
Cyclosporin A potentiates the cytotoxic effects of methyl methanesulphonate in HL-60 and K562 cells.
Topics: Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Caspase 3; Cell Survival; Cyclosporine; DNA Damage; DNA, Neoplasm; Dose-Response Relationship, Drug; Drug Synergism; Glutathione; Glutathione Disulfide; HL-60 Cells; Humans; Immunosuppressive Agents; K562 Cells; Methyl Methanesulfonate; Necrosis; Oxidative Stress; RNA, Messenger; RNA, Neoplasm | 2007 |